A Fenbendazole, Panacur, Safe-Guard CEP of the European Pharmacopoeia monograph is often referred to as a Fenbendazole, Panacur, Safe-Guard Certificate of Suitability (COS). The purpose of a Fenbendazole, Panacur, Safe-Guard CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Fenbendazole, Panacur, Safe-Guard EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Fenbendazole, Panacur, Safe-Guard to their clients by showing that a Fenbendazole, Panacur, Safe-Guard CEP has been issued for it. The manufacturer submits a Fenbendazole, Panacur, Safe-Guard CEP (COS) as part of the market authorization procedure, and it takes on the role of a Fenbendazole, Panacur, Safe-Guard CEP holder for the record. Additionally, the data presented in the Fenbendazole, Panacur, Safe-Guard CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Fenbendazole, Panacur, Safe-Guard DMF.
A Fenbendazole, Panacur, Safe-Guard CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Fenbendazole, Panacur, Safe-Guard CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Fenbendazole, Panacur, Safe-Guard suppliers with CEP (COS) on PharmaCompass.